Cargando…
Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
We performed a case-control study to evaluate the association between antibiotic use and Clostridium difficile–associated diarrhea (CDAD), matching for admission unit and time at risk for CDAD. A multivariable regression model showed that treatment with fluoroquinolones (odds ratio 12.7; 95% confide...
Autores principales: | McCusker, Margaret E., Harris, Anthony D., Perencevich, Eli, Roghmann, Mary-Claire |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000134/ https://www.ncbi.nlm.nih.gov/pubmed/12781017 http://dx.doi.org/10.3201/eid0906.020385 |
Ejemplares similares
-
Fluoroquinolone Resistance and Clostridium difficile, Germany
por: Zaiß, Nils Henning, et al.
Publicado: (2010) -
ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease
por: Dubberke, Erik R., et al.
Publicado: (2006) -
Clostridium difficile–associated Disease in New Jersey Hospitals, 2000–2004
por: Tan, Esther T., et al.
Publicado: (2007) -
Clostridium difficile in Retail Meat Products, USA, 2007
por: Songer, J. Glenn, et al.
Publicado: (2009) -
Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones
por: Walbrown, Molly A., et al.
Publicado: (2008)